專家信息：

揭志軍，男，1973年出生，醫(yī)學博士，主任醫(yī)師， 復旦大學附屬上海市第五人民醫(yī)院呼吸與危重癥醫(yī)學科主任、內科規(guī)范化培訓基地教學主任。復旦大學博士生導師，上海市第二批衛(wèi)生系統(tǒng)優(yōu)秀學科帶頭人，閔行區(qū)領軍人才，美國新墨西哥州Lovelace呼吸病研究訪問學者，上海市“區(qū)域名醫(yī)”。

教育及工作經歷：

1996年，畢業(yè)于武漢同濟醫(yī)科大學，學術學位。

1996-1999，就讀于復旦大學研究生院，碩士學位。

2002-2005，就讀于復旦大學研究生院，博士學位。

2005.12-2007.3，赴美國新墨西哥州Lovelace呼吸病研究所學習。

1999.7-2011.1，在新華醫(yī)院呼吸內科工作。

2011.2月，調至復旦大學附屬上海市第五人民醫(yī)院，為呼吸內科副主任（主持工作），副主任醫(yī)師。

學術兼職及社會任職：

 揭志軍主任現擔任中華醫(yī)學會呼吸病分會基層呼吸學組副組長，上海基層呼吸疾病防治聯(lián)盟執(zhí)行主席；中華醫(yī)學會呼吸病分會感染學組委員、中國醫(yī)師協(xié)會中西醫(yī)結合醫(yī)師分會呼吸病學常務委員、上海市醫(yī)學會呼吸病專業(yè)委員會委員兼感染學組副組長、上海市醫(yī)師協(xié)會呼吸內科醫(yī)師分會（第二屆）委員會委員兼秘書等職務

       1.上海市藥學會藥物治療專業(yè)委員會委員。

2.上海中西醫(yī)結合委員會呼吸系統(tǒng)疾病專業(yè)委員會委員。

3.上海醫(yī)學會肺科學會感染學組和危重學組成員。

4.中國醫(yī)師協(xié)會呼吸病分會中青年委員。

5.中國中西醫(yī)結合委員會呼吸專業(yè)委員會委員。

6.上海市醫(yī)學會呼吸病專業(yè)委員會青年委員。

7.上海市藥學會藥物治療專業(yè)委員會委員。

8.上海市醫(yī)學會變態(tài)反應分會青年委員。

主講課程：

資料更新中…… 

培養(yǎng)研究生情況：

目前已招收6名碩士研究生，還招收皖南醫(yī)學院碩士生3名。

 

研究方向：

呼吸道病毒感染的免疫調控和哮喘發(fā)病機制研究。

擅 長：哮喘和慢性阻塞性肺疾病（COPD）的規(guī)范化治療，肺部感染、肺癌等疾病的診治。

承擔科研項目情況：

主持國家自然科學基金面上項目、國家自然科學基金青年項目、上海市科委課題、上海市衛(wèi)生局科技基金、復旦大學青年啟動基金等多項課題。

科研成果：

1. 2013年4月，作為人感染H7N9禽流感病毒發(fā)現者之一，以并列第一作者在國際頂尖醫(yī)學期刊《新英格蘭醫(yī)學雜志》發(fā)表了發(fā)現新型人感染H7N9禽流感病毒的論文。

2. 以第一作者或通訊作者發(fā)表論文30余篇，其中SCI論文8篇，影響因子合計超過70分。2013年獲得上海市醫(yī)學會呼吸病結核病學分會聯(lián)合年會優(yōu)秀論文獎1篇。

3. 2013年，所領導科室被醫(yī)院評為“科研優(yōu)勝獎”“綜合優(yōu)勝獎”“醫(yī)療成果優(yōu)勝獎”等多項獎勵。 

4. 骨髓間充質干細胞移植對大鼠酸性胃內容物所致吸入性肺損傷的保護作用及機制探討 施勁東;揭志軍;李善群;謝娟;冷蓓崢;隆玄;周敬;吳曉丹;周韻嬌;符翠萍;朱芬;陶悅璐;許賓;高育瑤 復旦大學附屬上海市第五人民醫(yī)院 2013 

5. 血循環(huán)中輔助性T淋巴細胞17(Th17)表達與肺癌的關系 揭志軍;陳智偉;何燕超;向明;鄢莉宏;施勁東;周韻嬌;錢凌;梅周芳 復旦大學附屬上海市第五人民醫(yī)院 2014 

6. 人感染新型H7N9禽流感病毒的發(fā)現及其病原學研究 舒躍龍;管軼;袁正宏;王大燕;朱華晨;周劍芳;高榮保;胡蕓文;張曦;曹彬;王宇;高福;武桂珍;揭志軍;蔣太交 中國疾病預防控制中心病毒病預防控制所 2013 

7. 人感染新型H7N9禽流感病毒的發(fā)現及其病原學 舒躍龍;管軼;袁正宏;王大燕;朱華晨;周劍芳;高榮保;胡蕓文;張曦;曹彬;王宇;高福;武桂珍;揭志軍;蔣太交 中國疾病預防控制中心病毒病預防控制所 2013

發(fā)明專利:

[1]施天昀,揭志軍. 一種射頻消融電極針固定裝置[P]. 上海市: CN219700092U, 2023-09-19.

[2]梅周芳, 揭志軍, 陳鴻軍. 一種黃芪甲苷類化合物的藥物用途[P]. 上海市: CN112353809B, 2022-01-04.

[3]施天昀, 都勇, 揭志軍. 一種支氣管鏡活檢裝置[P]. 上海市: CN214104476U, 2021-09-03.

[4]梅周芳, 揭志軍, 陳鴻軍. 一種黃芪甲苷類化合物的藥物用途[P]. 上海市: CN112353809A, 2021-02-12.

[5]梅周芳, 揭志軍. 一種簡易式醫(yī)用利器盒[P]. 上海市: CN209301914U, 2019-08-27.

[6]梅周芳, 揭志軍. 一種具有定位計數功能的肺穿刺活檢針[P]. 上海市: CN208551868U, 2019-03-01.

[7]蔣蓉, 陳家君, 揭志軍. 一次性胸腔/腹腔體液引流管固定裝置[P]. 上海: CN208031642U, 2018-11-02.

[8]施天昀, 何燕超, 孫偉, 揭志軍. 一種構建哮喘免疫耐受模型的方法[P]. 上海: CN108114272A, 2018-06-05.

 

論文專著：

發(fā)表論文30余篇，其中SCI論文8篇，影響因子70多分，主編專著3本。

1.《支氣管哮喘咨詢》

2.《老年人群疾病與醫(yī)療保障》

代表性英文論文：

[1]Yin, Xin; Zheng, Zixuan; Dong, Yue; Li, Junqing; Yang, Shuang; Xu, Qian; Hou, Shanshan; Zang, Yi; Ding, Heyuan; Xie, Juan; Jie, Zhijun; Jiang, Qingwu; Shi, Jindong*; Wang, Na*.Comparison of newly diagnosed COPD patients and the non-COPD residents in Shanghai Minhang District.Frontiers in Public Health, 2023, 11: 1102509.

[2]Zhu, Yuanshou; Zhang, Meng; Guo, Shujuan; Xu, Hong; Jie, Zhijun*; Tao, Sheng-ce*.CRISPR-based diagnostics of different biomolecules from nucleic acids, proteins, and small molecules to exosomes.Acta Biochimica et Biophysica Sinica, 2023, 55(10): 1539-1550. 

[3]Mei, Zhoufang; Zhang, Jing; Chen, Xuru; He, Yanchao; Feng, Jingjing; Du, Yong; Shi, Jindong; Jie, Zhijun*.Systems pharmacology approach to explore the mechanisms of shufeng Jiedu Capsule on treating H1N1 infection.Drug Development and Industrial Pharmacy, 2023, 49(6): 405-415.

[4]Kurai, Daisuke; Song, JoonYoung; Huang, Yhu-Chering; Jie, Zhijun; Atanasov, Petar; Jiang, Xiaobin; Hernandez-Pastor, Luis; Huang, Tom Hsun-Wei; Park, SeongBeom; Lim, KyungHwa; Richmond, Peter C.*.Targeted Literature Review of the Burden of Respiratory Syncytial Infection among High-Risk and Elderly Patients in Asia Pacific Region.Infectious Diseases and Therapy, 2023, 12(3): 807-828.

[5]Zuo, Yi-Hui; Wu, Yi-Xing; Hu, Wei-Ping; Chen, Yan; Li, Yu-Ping; Song, Zhen-Ju; Luo, Zhe; Ju, Min-Jie; Shi, Min-Hua; Xu, Shu-Yun; Zhou, Hua; Li, Xiang; Jie, Zhi-Jun; Liu, Xue-Dong; Zhang, Jing*.The Clinical Impact of Metagenomic Next-Generation Sequencing (mNGS) Test in Hospitalized Patients with Suspected Sepsis: A Multicenter Prospective Study.Diagnostics, 2023, 13(2): 323. 

[6]Li, Na; Shi, Tianyun; Zhang, Meng; He, Yanchao; Feng, Jingjing; Mei, Zhoufang; Su, Xiao*; Jie, Zhijun*.PLZF promotes the development of asthma tolerance via affecting memory phenotypes of immune cells.International Immunopharmacology, 2023, 114: 109559.

[7]Mei, Zhou-Fang; Yan, Jing; Qian, Ling; He, Yan-Chao; Feng, Jing-Jing; Wang, Jie; Jie, Zhi-Jun*; Zou, Hua*.Enrichment of Circulating Tumor Cells of Lung Cancer and Correlation With Serum Leukomonocyte and Tumor Biomarkers: A Retrospective Study.Technology in Cancer Research and Treatment, 2023, 22: 15330338231167827.

[8]Zeng Yingying; Guan Weijie; Wang Kai; Jie Zhijun; Zou Xu; Tan Xiaoping; Li Xinyu; Chen Xiaohua; Ren Xiaoting; Jiang Junhong; Zheng Zeguang; Shi Jindong; Zhong Nanshan.Effect of hydrogen/oxygen therapy for ordinary COVID-19 patients: a propensity-score matched case-control study.BMC Infectious Diseases, 2023, 23(1).

[9]Gao, Yong-Hua; Lu, Hai-Wen; Mao, Bei; Guan, Wei-Jie; Song, Yuan-Lin; Li, Yuan-Yuan; Wang, Dao-Xin; Wang, Bin; Gu, Hong-Yan; Li, Wen; Luo, Hong; Wang, Ling-Wei; Li, Fan; Guo, Feng-Xia; Zhang, Min; Jie, Zhi-Jun; Hang, Jing-Qing; Yang, Chao; Ren, Tao; Yuan, Zhi; Meng, Qing-Wei; Jia, Qin; Chen, Yu; Chen, Rong-Chang*; Qu, Jie-Ming*; Xu, Jin-Fu*.The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study.Respiratory Research, 2022, 23(1): 328.

[10]Zhu, Yuanshou; Zhang, Meng; Jie, Zhijun*; Tao, Shengce*.Nucleic acid testing of SARS-CoV-2: A review of current methods, challenges, and prospects.Frontiers in Microbiology, 2022, 13: 1074289.

[11]Li, Na; Chen, Jie; Xie, Sitao; Zhang, Meng; Shi, Tianyun; He, Yanchao; Jie, Zhijun*; Su, Xiao*.Oral antibiotics relieve allergic asthma in post-weaning mice via reducing iNKT cells and function of ADRB2.Frontiers in Immunology, 2022, 13: 1024235.

[12]Dong, Yue; Wang, Kai; Zou, Xu; Tan, Xiaoping; Zang, Yi; Li, Xinyu; Ren, Xiaoting; Xie, Desheng; Jie, Zhijun; Chen, Xiaohua; Zeng, Yingying*; Shi, Jindong*.Evaluating the ability of the NLHA2 and artificial neural network models to predict COVID-19 severity, and comparing them with the four existing scoring systems.Microbial Pathogenesis, 2022, 171: 105735.

[13]Du, Yong; Ding, Yi; Shi, Tianyun; He, Wei; Mei, Zhoufang; Feng, Xintong; Zhang, Xiaohua; Jie, Zhijun*.Suppression of circXPO1 attenuates cigarette smoke-induced inflammation and cellular senescence of alveolar epithelial cells in chronic obstructive pulmonary disease.International Immunopharmacology, 2022, 111: 109086. 

[14]Zhang, Meng; He, Yanchao; Jie, Zhijun*.Delta variant: Partially sensitive to vaccination, but still worth global attention.JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2022, 10(3): 227-235.

[15]Zhang, Meng; Li, Na; He, Yanchao; Shi, Tianyun; Jie, Zhijun*.Pulmonary resident memory T cells in respiratory virus infection and their inspiration on therapeutic strategies.Frontiers in Immunology, 2022, 13: 943331.

[16]Du, Yong; Ding, Yi; Shi, Tianyun; He, Wei; Feng, Jingjing; Mei, Zhoufang; Chen, Xuru; Feng, Xintong; Zhang, Xiaohua; Jie, Zhijun*. Long noncoding RNA GAS5 attenuates cigarette smoke-induced airway remodeling by regulating miR-217-5p/PTEN axis.Acta Biochimica et Biophysica Sinica, 2022, 54(7): 931-939.

[17]Feng, Jingjing; Li, Junqing; Du, Yong; Shi, Tianyun; Sharma, Lokesh; Jie, Zhijun*.Case Report: Rare Dynein Axonemal Heavy Chain 9 Mutations in a Han-Chinese Patient With Kartagener Syndrome.Frontiers in Medicine, 2022, 9: 893968.

[18]Peng Bo; Sun Lin; Shang Yan; Zhang Yajuan; Gao Xiwen; Ye Ling; Jin Meiling; He Wei; Jie Zhijun; Du Chunling; Zhou Lei; Liu Yang; Song Xiaolian; Du Juan; Zhang Fengying; Gong Yi; Shi Yuheng; Bao Wuping; Chen Haihua; Wang Jin; Wen Chijun; Li Weihao; Zhao Dandan; Wang Gang; Zhou Xin; Tang Wei.Translation and validation of the Chinese version of Patient-completed Asthma Knowledge Questionnaire and its implementation in patient education.Journal of Thoracic Disease, 2022, 14(4).

[19]Dong Yue; Wang Kai; Zou Xu; Tan Xiaoping; Zang Yi; Li Xinyu; Ren Xiaoting; Xie Desheng; Jie Zhijun; Chen Xiaohua; Zeng Yingying; Shi Jindong.Evaluating the ability of the NLHA2 and artificial neural network models to predict COVID-19 severity, and comparing them with the four existing scoring systems.Microbial Pathogenesis, 2022, 171.

[20]Yang, Shuang; Yin, Xin; Zhang, Yanan; Zhao, Hanwei; Zheng, Zixuan; Li, Junqing; Hu, Xiaoying; Xie, Juan; Jie, Zhijun; Wang, Na*; Shi, Jindong*.Efficacy of a Self-Designed Questionnaire for Community Screening of COPD.International Journal of Chronic Obstructive Pulmonary Disease, 2022, 17: 1381-1391.

[21]Du Yong; Ding Yi; Shi Tianyun; He Wei; Mei Zhoufang; Feng Xintong; Zhang Xiaohua; Jie Zhijun.Suppression of circXPO1 attenuates cigarette smoke-induced inflammation and cellular senescence of alveolar epithelial cells in chronic obstructive pulmonary disease.International Immunopharmacology, 2022, 111.

[22]Yong Du; Yi Ding; Tianyun Shi; Wei He; Jingjing Feng; Zhoufang Mei; Xuru Chen; Xintong Feng; Xiaohua Zhang; Zhijun Jie.Long noncoding RNA GAS5 attenuates cigarette smoke-induced airway remodeling by regulating miR-217-5p/PTEN axis.Acta Biochimica et Biophysica Sinica, 2022, (7): 931-939.

[23]Liu, Yang; Lu, Hai-Wen; Gu, Shu-Yi; Wang, Wen-Wen; Ge, Juan; Jie, Zhi-Jun; Jia, Jin-Guang; Gao, Zhi-Ting; Li, Jun; Shi, Jing-Yun; Liang, Shuo; Cheng, Ke-Bing; Bai, Jiu-Wu; Qu, Jie-Ming*; Xu, Jin-Fu*.Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis.EBioMedicine, 2021, 72: 103587.

[24]Du, Yong; Lu, Zhanjun; Jin, Jing; Shi, Tianyun; Ding, Yi; Qian, Ling; He, Wei; Huang, Qihui; Feng, Jingjing; Jiang, Rong; Chen, Xuru; Jiang, Handong*; Jie, Zhijun*.Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit.International Immunopharmacology, 2021, 97: 107697.

[25]Shi, Tianyun; Li, Na; He, Yanchao; Feng, Jingjing; Mei, Zhoufang; Du, Yong; Jie, Zhijun*.Th17/Treg cell imbalance plays an important role in respiratory syncytial virus infection compromising asthma tolerance in mice.Microbial Pathogenesis, 2021, 156: 104867.

[26]Ye, Ling; Gao, Xiwen; Tu, Chunlin; Du, Chunling; Gu, Wenchao; Hang, Jingqing; Zhao, Lei; Jie, Zhijun; Li, Hailing; Lu, Yueming; Wang, Jin; Jin, Xiaoyan; Hu, Xiao; Wu, Shunquan; Jin, Meiling*.Comparative analysis of effectiveness of asthma control test-guided treatment versus usual care in patients with asthma from China.Respiratory Medicine, 2021, 182: 106382.

[27]Feng, Jingjing; Xu, Jinfu; Xu, Susu; Cao, Huifang; Zheng, Cuixia; Sharma, Lokesh; Dela Cruz, Charles S.; Zhang, Jing; Chu, Dejie; Yu, Li; Tu, Chunlin; Li, Fan; Ren, Tao; Zhang, Fengying; Du, Chunlin; Gu, Wenchao; Liu, Hongwei; Qian, Yechang; Shen, Changxing; Tang, Chunhong; Bi, Yueping; Xiao, Feng; Gu, Kejia; Zhang, Jie; Ye, Zheng; Zhao, Liang; Zhai, Jiayi; Hu, Xiaoying; Qu, Jieming*; Jie, Zhijun.Psychological Impact During the First Outbreak of COVID-19 on Frontline Health Care Workers in Shanghai.Frontiers in Public Health, 2021, 9: 646780.

[28]Zheng, Ze-Guang*; Sun, Wu-Zhuang; Hu, Jie-Ying; Jie, Zhi-Jun; Xu, Jin-Fu; Cao, Jie; Song, Yuan-Lin; Wang, Chang-Hui; Wang, Jing; Zhao, Hui; Guo, Zhong-Liang; Zhong, Nan-Shan*.Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial.Respiratory Research, 2021, 22(1): 149.

[29]Feng, Xintong; Zhao, Caiqi; Li, Ling; Feng, Jingjing; He, Wei; Shi, Tianyun; Li, Na; Jie, Zhijun; Su, Xiao*.iNKT cells with high PLZF expression are recruited into the lung via CCL21-CCR7 signaling to facilitate the development of asthma tolerance in mice.European Journal of Immunology, 2021, 51(2): 414-432.

[30]Feng, Xintong; Li, Ling; Feng, Jingjing; He, Wei; Li, Na; Shi, Tianyun; Jie, Zhijun*; Su, Xiao*.Vagal-alpha 7nAChR signaling attenuates allergic asthma responses and facilitates asthma tolerance by regulating inflammatory group 2 innate lymphoid cells.Immunology and Cell Biology, 2021, 99(2): 206-222. 

[31]Ge, Haiyan; Liu, Xuanqi; Gu, Wenchao; Feng, Xiumin; Zhang, Fengying; Han, Fengfeng; Qian, Yechang; Jin, Xiaoyan; Gao, Beilan; Yu, Li; Bao, Hong; Zhou, Min; Li, Shengqing; Jie, Zhijun; Wang, Jian; Chen, Zhihong; Hang, Jingqing; Zhang, Jingxi*; Zhu, Huili*.Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP.Journal of Inflammation Research, 2021, 14: 3335-3348.

[32]Feng Xintong; Zhao Caiqi; Li Ling; Feng Jingjing; He Wei; Shi Tianyun; Li Na; Jie Zhijun; Su Xiao.iNKT cells with high PLZF expression are recruited into the lung via CCL21-CCR7 signaling to facilitate the development of asthma tolerance in mice.European Journal of Immunology, 2020, 51(2). 

[33]Lu, Shun*; Chen, Gongyan; Sun, Yuping; Sun, Sanyuan; Chang, Jianhua; Yao, Yu; Chen, Zhendong; Ye, Feng; Lu, Junguo; Shi, Jianhua; He, Jianxing; Liu, Xiaoqing; Zhang, Yiping; Liu, Zhihua; Fang, Jian; Cheng, Ying; Hu, Chunhong; Mao, Weidong; Hu, Yanping; Gong, Youling; Shan, Li; Yang, Zhixiong; Song, Yong; Li, Wei; Bai, Chong; Wang, Buhai; Ma, Rui; Zheng, Zhendong; Liu, Mingfang; Jie, Zhijun; Cao, Lejie; Liao, Wangjun; Pan, Hongming; Huang, Dongning; Chen, Yuan.A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer - The FALUCA study.Lung Cancer, 2020, 146(C): 252-262.

[34]Mao, Bei; Liu, Yang; Chai, Yan-Hua; Jin, Xiao-Yan; Lu, Hai-Wen; Yang, Jia-Wei; Gao, Xi-Wen; Song, Xiao-Lian; Bao, Hong; Wang, An; Gu, Wen-Chao; Zhao, Lei; Pan, Jie-Ping; Li, Fan; Zhang, Tie-Feng; Qian, Ye-Chang; Du, Chun-Ling; Ding, Wei; Tu, Chun-Lin; Chu, De-Jie; Li, Chun; Ye, Ling; Luo, Yong; Zheng, Cui-Xia; Yu, Rong-Huan; Qiu, Zhong-Min; Cao, Hui-Fang; Ren, Jia-Wei; Zhao, Jing-Ya; Wang, Chang-Hui; Lu, Hong-Zhou; Li, Jun; Hu, Yang; Liang, Shuo; Jie, Zhi-Jun; Qu, Jie-Ming.Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study.Lancet Digital Health, 2020, 2(6): E323-E330.

[35]Li, Na; Jie, Zhijun*.The application of corticosteroids in COVID-19: A two-edged sword.JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2020, 8(2): 66-70.

[36]Liu, Yang; Mao, Bei; Liang, Shuo; Yang, Jia-Wei; Lu, Hai-Wen; Chai, Yan-Hua; Wang, Lan; Zhang, Li; Li, Qiu-Hong; Zhao, Lan; He, Yan; Gu, Xiao-Long; Ji, Xiao-Bin; Li, Li; Jie, Zhi-Jun; Li, Qiang; Li, Xiang-Yang; Lu, Hong-Zhou; Zhang, Wen-Hong; Song, Yuan-Lin; Qu, Jie-Ming; Xu, Jin-Fu*.Association between age and clinical characteristics and outcomes of COVID-19.European Respiratory Journal, 2020, 55(5): 2001112.

[37]Lin, Jiangtao*; Fu, Xiuhua; Jiang, Ping; Song, Weidong; Hu, Xiaoyun; Jie, Zhijun; Liu, Chuntao; He, Zhengguang; Zhou, Xiangdong; Tang, Huaping.Post hoc analysis of initial treatments and control status in the INITIAL study: an observational study of newly diagnosed patients with asthma.BMC Pulmonary Medicine, 2020, 20(1): 87. 

[38]Hu, Wei-Ping; Zhang, Feng-Ying; Zhang, Jing*; Hang, Jing-Qing; Zeng, Ying-Ying; Du, Chun-Ling; Jie, Zhi-Jun; Jin, Xiao-Yan; Zheng, Cui-Xia; Luo, Xu-Ming; Huang, Yi; Cheng, Qi-Jian; Qu, Jie-Ming*.Initial diagnosis and management of adult community-acquired pneumonia: a 5-day prospective study in Shanghai.Journal of Thoracic Disease, 2020, 12(4): 1417-1426.

[39]Shi, Jindong; Li, Jiannan; Yang, Shuang; Hu, Xiaoying; Chen, Jiajun; Feng, Jingjing; Shi, Tianyun; He, Yanchao; Mei, Zhoufang; He, Wei; Xie, Juan; Li, Shanqun; Jie, Zhijun*; Tu, Shuiping*.LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-beta pathway and IL-6/JAK2/STAT3 pathway.Journal of Cellular Physiology, 2020, 235(3): 2891-2900.

[40]Zhang, Jing; Zhang, Wanju; Ren, Lehao; He, Yanchao; Mei, Zhoufang; Feng, Jingjing; Shi, Tianyun; Zhang, Huiying; Song, Zhigang; Jie, Zhijun*.Astragaloside IV attenuates IL-1 beta secretion by enhancing autophagy in H1N1 infection.FEMS Microbiology Letters, 2020, 367(4): fnaa007.

[41]Liu Xuanqi; Ge Haiyan; Feng Xiumin; Hang Jingqing; Zhang Fengying; Jin Xiaoyan; Bao Hong; Zhou Min; Han Fengfeng; Li Shengqing; Qian Yechang; Jie Zhijun; Gu Wenchao; Gao Beilan; Yu Li; Wang Jian; Ji Haiying; Zhang Jingxi; Zhu Huili.The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease.Frontiers in Medicine, 2020, 7.

[42]Lin Jiangtao*; Fu Xiuhua; Jiang Ping; Song Weidong; Hu Xiaoyun; Jie Zhijun; Liu Chuntao; He Zhengguang; Zhou Xiangdong; Tang Huaping.INITIAL - An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks' treatment.Scientific Reports, 2019, 9: 1254.

[43]Du, Yong; Zhang, Hui; Xu, Yan; Ding, Yi; Chen, Xuru; Mei, Zhoufang; Ding, Heyuan; Jie, Zhijun*.Association among genetic polymorphisms of GSTP1, HO-1, and SOD-3 and chronic obstructive pulmonary disease susceptibility.International Journal of Chronic Obstructive Pulmonary Disease, 2019, 14: 2081-2088.

[44]Huang, Yi; Jiao, Yang; Zhang, Jing; Xu, Jinfu; Cheng, Qijian; Li, Yi; Liang, Shuo; Li, Huayin; Gong, Jin; Zhu, Yinggang; Song, Lin; Rong, Zhaohui; Liu, Bin; Jie, Zhijun; Sun, Shuo; Li, Ping; Wang, Guifang; Qu, Jieming*.Microbial Etiology and Prognostic Factors of Ventilator-associated Pneumonia: A Multicenter Retrospective Study in Shanghai.Clinical Infectious Diseases, 2018, 67: S146-S152.

[45]He, Wei; Ju, Dandan; Jie, Zhijun; Zhang, Ai*; Xing, Xin*; Yang, Qin*.Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma.Cancer Medicine, 2018, 7(11): 5716-5726.

[46]Yin, Tiping; Zhu, Zhaoqin; Mei, Zhoufang; Feng, Jingjing; Zhang, Wanju; He, Yanchao; Shi, Jindong; Qian, Ling; Liu, Yi; Huang, Qihui; Hu, Yunwen*; Jie, Zhijun*.Analysis of viral infection and biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease.Clinical Respiratory Journal, 2018, 12(3): 1228-1239.

[47]Qian, Ling*; Pan, Shiying; Shi, Jingdong; Du, Yong; Huang, Qihui; Jie, Zhijun.Association between fractional exhaled nitric oxide (FeNO) cutoff values (25 ppb) and risk factors of cough.Clinical Respiratory Journal, 2018, 12(1): 193-199. 

[48]Shi, Jindong; Feng, Jingjing; Xie, Juan; Mei, Zhoufang; Shi, Tianyun; Wang, Shengmei; Du, Yong; Yang, Gong; Wu, Yougen; Cheng, Xiaojiao; Li, Shanqun; Zhu, Liming; Yang, Chung S; Tu, Shuiping*; Jie, Zhijun*.Targeted blockade of TGF-beta and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts.Scientific Reports, 2017, 7(1): 8660. 

[49]Du, Yong; Ding, Yi; Chen, Xuru; Mei, Zhoufang; Ding, Heyuan; Wu, Yi; Jie, Zhijun*.MicroRNA-181c inhibits cigarette smoke-induced chronic obstructive pulmonary disease by regulating CCN1 expression.Respiratory Research, 2017, 18(1): 155. 

[50]He, Yanchao; Du, Yong; Wei, Sun; Shi, Jindong; Mei, Zhoufang; Qian, Ling; Chen, Zhiwei*; Jie, Zhijun*.IL-17A and IL-17F single nucleotide polymorphisms associated with lung cancer in Chinese population.Clinical Respiratory Journal, 2017, 11(2): 230-242.

[51]Du, Yong; He, Yanchao; Mei, Zhoufang; Qian, Ling; Shi, Jindong; Jie, Zhijun*.Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population.Clinical Respiratory Journal, 2016, 10(3): 311-317.

[52]Feng, Jingjing; Hu, Yunwen; Song, Zhigang; Liu, Yi; Guo, Xuejun; Jie, Zhijun*.Interleukin-23 Facilitates Th1 and Th2 Cell Differentiation In Vitro Following Respiratory Syncytial Virus Infection.Journal of Medical Virology, 2015, 87(4): 708-715.

[53]He Yanchao; Sun Wei; Shi Jindong; Su Xiao; Jie Zhijun.LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma.European Respiratory Journal, 2015, 46(s59).

[54]Zhang Wanju; He Yanchao; Xu Lei; Dai Fahui; Mei Zhoufang; Qian Ling; Xie Desheng; Shen Ying; Gu Yong; Zhang Zhiyong; Yuan Zhenghong; Jie Zhijun; Hu Yunwen.Full-Genome Analysis of Influenza A(H7N9) Virus from Shanghai, China, 2014.Genome announcements, 2014, 2(3).

[55]Mei Z, He Y, Feng J, Shi J, Du Y, Qian L, Huang Q, Jie Z*. MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2. FEBS Letters, 2014, 588(17): 3056-3061.. 2014 Jun 16. pii: S0014-5793(14)00479-7. （通訊作者：揭志軍）（IF=3.58）

[56]Shi, Jindong; Xie, Juan; He, Zebao; Hu, Yunwen; He, Yanchao; Huang, Qihui; Leng, Beizheng; He, Wei; Sheng, Ying; Li, Fangming; Song, Yuanlin; Bai, Chunxue; Gu, Yong*; Jie, Zhijun*.A Detailed Epidemiological and Clinical Description of 6 Human Cases of Avian-Origin Influenza A (H7N9) Virus Infection in Shanghai.PLos One, 2013, 8(10): e77651.doi: 10.1371/journal.pone.0077651. （通訊作者：揭志軍）（IF=3.73）

[57]Gao, Rongbao; Cao, Bin; Hu, Yunwen; Feng, Zijian; Wang, Dayan; Hu, Wanfu; Chen, Jian; Jie, Zhijun*; Qiu, Haibo; Xu, Ke; Xu, Xuewei; Lu, Hongzhou; Zhu, Wenfei; Gao, Zhancheng; Xiang, Nijuan; Shen, Yinzhong; He, Zebao; Gu, Yong; Zhang, Zhiyong; Yang, Yi; Zhao, Xiang; Zhou, Lei; Li, Xiaodan; Zou, Shumei; Zhang, Ye; Li, Xiyan; Yang, Lei; Guo, Junfeng; Dong, Jie; Li, Qun; Dong, Libo; Zhu, Yun; Bai, Tian; Wang, Shiwen; Hao, Pei; Yang, Weizhong; Zhang, Yanping; Han, Jun; Yu, Hongjie; Li, Dexin.Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus.New England Journal of Medicine, 2013, 368(20): 1888-1897.（并列第一作者）(IF=51.6)

[58]Jie Z, Xie J, He Z, Song Y, Hu Y, Li F, Shen Y, Shi J, He Y, Huang Q, Gu Y, Bai C. Family outbreak of severe pneumonia induced by H7N9 infection. Am J Respir Crit Care Med, 2013; 188(1): 114-115. （IF=11）  

[59]Jie, Zhijun; Hu, Zhilin; Bai, Chunxue; Jin, Meiling*.ADAM33 Gene Polymorphisms Associate with Asthma Susceptibility and Severity in East China Han Population.Journal of Asthma, 2011, 48(10): 979-985.

[59]Jie, Zhijun; Dinwiddie, Darrell L.; Senft, Albert P.; Harrod, Kevin S.*.Regulation of STAT signaling in mouse bone marrow derived dendritic cells by respiratory syncytial virus.Virus Research, 2011, 156(1-2): 127-133.（IF=2.94）

[60]Jie Z, Hu Z, Bai C, Jin M. ADAM33 Gene Polymorphisms Associate with Asthma Susceptibility and Severity in East China Han Population. J Asthma 2011 Dec;48(10):979-85. (IF=1.52)

[61]Jie Zhijun; Jin Meiling*; Cai Yingyun; Bai Chunxue; Shen Yao; Yuan Zhenghong; Hu Yunwen; Holgate Stephen. The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation.Respiratory Physiology & Neurobiology, 2009, 168(3): 289-294. （IF=2.13）

發(fā)表中文期刊論文： 

[1]揭志軍, 沙家鳳, 張萌. 新型冠狀病毒重復感染和應對[J]. 內科理論與實踐, 2024, 19 (01): 25-30.

[2]馮凈凈, 邵川, 李俊卿, 施天昀, 都勇, 揭志軍*, 施勁東*. 抑制p38絲裂素活化蛋白激酶途徑調控Th17和Treg失衡減輕脂多糖誘導的小鼠急性肺損傷[J]. 中國呼吸與危重監(jiān)護雜志, 2023, 22 (01): 44-51.

[3]陳旭如, 揭志軍*, 錢凌, 丁怡, 蔣蓉, 張佳彥. 肺癌合并血管栓塞性疾病患者外周血凝血功能和炎癥因子變化及其臨床意義[J]. 山東醫(yī)藥, 2022, 62 (25): 1-5.

[4]胡小英; 張小華; 楊雙; 張亞男; 施勁東; 揭志軍*.醫(yī)聯(lián)體模式下社區(qū)綜合干預措施對社區(qū)居民流感疫苗接種率的影響.國際呼吸雜志, 2022, 42(19): 1452-1458.

[5]任曉婷; 施天昀; 李娜; 何燕超; 錢凌; 馮凈凈; 梅周芳; 揭志軍*.早幼粒細胞白血病鋅指在哮喘患者外周血中的表達及意義.中華急診醫(yī)學雜志, 2022, 31(10): 1389-1395.

[6]何燕超, 揭志軍*. 綜合醫(yī)院活動性肺結核的早期篩查策略[J]. 結核與肺部疾病雜志, 2022, 3 (04): 334-337.

[7]何煒, 施天昀, 揭志軍*. 電子煙的危害[J]. 上海醫(yī)學, 2022, 45 (06): 438-440.

[8]于云霞; 揭志軍*.生物燃料COPD臨床特征及其與吸煙COPD差異研究進展.國際呼吸雜志, 2022, 42(12): 939-943. 

[9]何燕超, 張靜, 馮凈凈, 梅周芳, 錢凌, 黃琦慧, 揭志軍*. 成人社區(qū)獲得性肺炎合并呼吸道病毒感染住院患者病毒譜及臨床特征分析[J]. 中國全科醫(yī)學, 2021, 24 (26): 3323-3329.

[10]何燕超, 張靜, 馮凈凈, 揭志軍*. 流感病毒感染巨噬細胞對缺氧誘導因子-1α誘導炎癥反應通路的機制研究[J]. 微生物與感染, 2021, 16 (03): 164-170.

[11]蔣蓉, 陳旭如, 林麗萍, 曾瑩瑩, 董越, 王凱, 黃琦慧, 揭志軍, 施勁東*. 不同類型老年急性肺血栓栓塞癥患者臨床特征比較[J]. 老年醫(yī)學與保健, 2021, 27 (01): 51-55.

[12]馮凈凈, 陳家君, 施天昀, 何燕超, 揭志軍*. 白細胞介素-33抗體治療呼吸道合胞病毒誘導小鼠哮喘的效果觀察[J]. 微生物與感染, 2021, 16 (01): 2-9.

[13]馮秀敏, 葛海燕, 顧文超, 杭晶卿, 周敏, 韓鋒鋒, 錢葉長, 金曉燕, 李圣青, 高蓓蘭, 包紅, 余莉, 揭志軍, 王健, 張景熙, 朱惠莉. 上海地區(qū)部分二、三級甲等醫(yī)院穩(wěn)定期慢性阻塞性肺疾病患者合并癥特征調查及其臨床意義[J]. 第二軍醫(yī)大學學報, 2021, 42 (02): 177-188.

[14]陳家君, 馮凈凈, 施天昀, 陳鴻軍, 揭志軍. IL-33在呼吸道合胞病毒(RSV)感染致哮喘急性發(fā)作中的作用[J]. 復旦學報(醫(yī)學版), 2020, 47 (01): 59-65.

[15]梅周芳, 黃琪慧, 何艷超, 施天昀, 都勇, 施勁東, 揭志軍. 影像學表現易被誤診的侵襲性肺曲霉菌病分析[J]. 世界最新醫(yī)學信息文摘, 2019, 19 (A4): 1-2.

[16]湯葳, 周俊, 高習文, 張亞娟, 薛珉, 揭志軍, 杭晶卿, 俞烽, 魯立文, 宋瑞紅, 段玉香, 金曉燕, 程齊儉, 蔡曉婷, 羅劍鋒, 瞿介明. 聯(lián)合清肺抑火膠囊治療支氣管擴張癥急性加重的多中心隨機對照研究[J]. 中國呼吸與危重監(jiān)護雜志, 2019, 18 (04): 352-356.

[17]都勇, 丁怡, 陳旭如, 何煒, 施天昀, 揭志軍*. 阻塞性睡眠呼吸暫停低通氣綜合征患者自動調節(jié)持續(xù)氣道正壓通氣治療前后氧化應激水平的變化[J]. 臨床內科雜志, 2019, 36 (07): 451-454.

[18]梅周芳, 樊世琛, 施天昀, 都勇, 施勁東, 揭志軍. 同一街道連續(xù)2年3例人感染H7N9禽流感病毒臨床特征分析[J]. 轉化醫(yī)學電子雜志, 2018, 5 (12): 27-31.

[19]施勁東, 隆玄, 符翠萍, 李建楠, 謝娟, 施天昀, 梅周芳, 揭志軍, 李善群. 15-脫氧-Δ12,14-前列腺素J2對大鼠酸性胃內容物吸入性肺損傷的保護作用[J]. 中國臨床醫(yī)學, 2018, 25 (06): 905-909.

[20]何煒, 冷蓓崢, 揭志軍. 玉屏風散對支氣管哮喘小鼠白細胞介素-10和血管細胞黏附分子-1表達的影響[J]. 中醫(yī)藥信息, 2018, 35 (04): 55-58.

[21]王盛美, 揭志軍. 穩(wěn)定期COPD患者高碳酸血癥治療及預后的研究進展[J]. 醫(yī)學綜述, 2018, 24 (03): 522-526.

[22]馮凈凈, 陳家君, 王盛美, 揭志軍. 白細胞介素23在呼吸道合胞病毒感染致Th1、Th2及Th17細胞分化中的作用及機制[J]. 微生物與感染, 2017, 12 (05): 279-286.

[23]梅周芳, 陳家君, 施天昀, 都勇, 何煒, 陳鴻軍, 揭志軍. 黃芪甲苷對甲型H1N1流感病毒和呼吸道合胞病毒的抑制作用[J]. 中國動物傳染病學報, 2017, 25 (05): 5-10.

[24]丁怡, 陳旭如, 陳家君, 王盛美, 揭志軍, 都勇. 血清8-異前列腺F2α、丙二醛和過氧化氫酶在重疊綜合征患者中的臨床意義[J]. 河北醫(yī)藥, 2017, 39 (18): 2730-2733.

[25]梅周芳, 施天昀, 都勇, 何煒, 陳鴻軍, 揭志軍. 黃芪甲苷研究進展[J]. 臨床醫(yī)藥文獻電子雜志, 2017, 4 (03): 586-587.

[26]何燕超, 揭志軍, 施勁東, 梅周芳, 錢凌, 黃琦慧, 鄢莉宏. 慢性阻塞性肺疾病患者外周血Th17/CD25+Foxp3+Treg比率的變化[J]. 中國臨床醫(yī)學, 2016, 23 (06): 725-730.

[27]印體平, 揭志軍. 鼻病毒在慢性阻塞性肺疾病急性加重中的作用[J]. 醫(yī)學綜述, 2016, 22 (24): 4815-4819.

[28]梅周芳, 王張生, 施天昀, 都勇, 何煒, 揭志軍. 17例青年肺栓塞患者誤診原因分析[J]. 中西醫(yī)結合心血管病電子雜志, 2016, 4 (35): 140-141.

[29]吳宜, 揭志軍. 白細胞介素22在哮喘中的研究進展[J]. 醫(yī)學綜述, 2016, 22 (22): 4400-4404.

[30]何燕超, 施天昀, 施勁東, 梅周芳, 錢凌, 黃琦慧, 揭志軍. 白細胞介素27在呼吸道合胞病毒致肺部感染中的作用機制研究[J]. 中國呼吸與危重監(jiān)護雜志, 2016, 15 (04): 356-360.

[31]梅周芳, 秦欣宇, 潘星月, 趙露, 楊雨萌, 印體平, 施天昀, 揭志軍. 無免疫功能缺陷的肺隱球菌病19例誤診分析[J]. 臨床誤診誤治, 2016, 29 (01): 50-52.

[32]何燕超, 揭志軍. 白細胞介素27對哮喘免疫調控及治療的研究進展[J]. 醫(yī)學綜述, 2015, 21 (23): 4230-4233.

[33]范光德, 揭志軍. 生物標志物在肺動脈高壓中的應用[J]. 醫(yī)學綜述, 2015, 21 (22): 4069-4072.

[34]范光德, 梅周芳, 黃琦慧, 錢凌, 都勇, 施勁東, 揭志軍. 高齡老年人自發(fā)性乳糜胸誤診為慢性心力衰竭原因分析[J]. 臨床誤診誤治, 2015, 28 (07): 9-12.

[35]梅周芳, 錢凌, 都勇, 施勁東, 何煒, 揭志軍. 隱源性機化性肺炎反復誤診為社區(qū)獲得性肺炎[J]. 臨床誤診誤治, 2015, 28 (07): 12-15.

[36]何燕超, 施勁東, 梅周芳, 錢凌, 黃琦慧, 揭志軍. 非小細胞肺癌患者外周血Th17和Treg表達的意義[J]. 復旦學報(醫(yī)學版), 2015, 42 (03): 362-367.

[37]都勇, 揭志軍, 何煒. 痰熱清注射液對慢性阻塞性肺疾病急性加重期患者血清超敏C-反應蛋白及降鈣素原的影響研究[J]. 中華醫(yī)院感染學雜志, 2015, 25 (06): 1233-1235.

[38]錢凌, 揭志軍, 謝娟, 邵川, 朱芬, 劉子龍, 李善群, 施勁東. 基質金屬蛋白酶和金屬蛋白酶組織抑制劑對良惡性胸腔積液的鑒別診斷價值[J]. 中國臨床醫(yī)學, 2015, 22 (01): 54-56.

[39]梅周芳, 錢凌, 都勇, 施勁東, 何煒, 揭志軍. 變應性支氣管肺曲霉菌病誤診為支氣管哮喘臨床分析[J]. 臨床誤診誤治, 2015, 28 (02): 39-42.

[40]梅周芳, 錢凌, 都勇, 施勁東, 何煒, 李小靜, 揭志軍. 惡性胸膜間皮瘤誤診為結核性胸膜炎原因分析[J]. 臨床誤診誤治, 2015, 28 (01): 45-48.

[41]何靜; 徐磊; 王蔚; 管文彩; 田棣; 張萬菊; 劉祎; 錢方興; 揭志軍.2009-2011年上海ARTI人群中小RNA病毒感染的分子流行病學研究.中華實驗和臨床病毒學雜志, 2015, 29(5): 413-416. 

[42]梅周芳, 錢凌, 都勇, 施勁東, 何煒, 李小靜, 揭志軍. 原發(fā)性肺淋巴瘤誤診為肺癌原因討論[J]. 臨床誤診誤治, 2014, 27 (11): 13-16.

[43]都勇, 揭志軍, 何燕超, 錢凌. 著色性干皮病基因D和X線交叉互補修復基因1的多態(tài)性與肺癌的相關性分析[J]. 中國臨床醫(yī)學, 2014, 21 (03): 265-268.

[44]孫偉, 揭志軍. 吸入糖皮質激素和長效β2-受體激動劑復方制劑治療哮喘的研究進展[J]. 上海醫(yī)藥, 2014, 35 (05): 3-7.

[45]施勁東、何靜、胡蕓文、何燕超、黃琦慧、梅周芳、錢凌、蔣蓉、揭志軍。上海閔行地區(qū)老年慢性阻塞性肺疾病急性發(fā)作患者病毒感染分析。中華急診醫(yī)學雜志，2014；23（6）：667-671. （通訊作者：揭志軍） 

[46]梅周芳, 錢凌, 李小靜, 揭志軍. 壞死性肉芽腫性血管炎誤診為肺癌原因討論[J]. 臨床誤診誤治, 2013, 26 (06): 18-20.

[47]馮凈凈, 胡蕓文, 宋志剛, 揭志軍*, 郭雪君. 呼吸道合胞病毒感染小鼠Th17細胞亞群的變化[J]. 中國呼吸與危重監(jiān)護雜志, 2013, 12 (01): 49-54.（通訊作者）

[48]何煒, 揭志軍, 冷蓓崢, 鄢莉宏, 施勁東, 錢凌. COPD急性加重并呼吸衰竭患者無創(chuàng)正壓通氣治療失敗原因分析[J]. 臨床誤診誤治, 2012, 25 (08): 12-15.

[49]揭志軍, 馮凈凈, 宋志剛, 張悅, 郭雪君. 呼吸道合胞病毒(RSV)對干擾素(IFN)信號通路STAT蛋白核轉移的影響[J]. 復旦學報(醫(yī)學版), 2012, 39 (03): 277-282.

[50]鄧桂勝, 羅勇, 徐衛(wèi)國, 揭志軍, 王瑩. AECOPD氧化應激與肺功能、最大呼吸肌力動態(tài)變化相關性研究[J]. 臨床肺科雜志, 2012, 17 (01): 9-11.

[51]何靜, 龔燕, 張萬菊, 徐磊, 劉祎, 錢方興, 揭志軍, 俞慧菊, 李楊, 周志統(tǒng), 胡蕓文. 2009～2010年上海地區(qū)急性呼吸道感染病毒病原譜分析[J]. 微生物與感染, 2011, 6 (02): 90-96.

[52]王妍敏, 郭雪君, 韓鋒鋒, 孫依萍, 羅勇, 楊天蕓, 黃雁西, 揭志軍, 姚迪, 郟琴, 蔡蓉. 肺栓塞患者發(fā)熱情況臨床分析[J]. 實用醫(yī)學雜志, 2011, 27 (03): 468-470.

[53]馮凈凈; 揭志軍; 郭雪君.Th17細胞在病毒感染性疾病中作用的研究進展.國際呼吸雜志, 2011, 31(14): 1081-1085. 

[54]揭志軍. 支氣管擴張癥的治療原則[J]. 中國社區(qū)醫(yī)師, 2010, 26 (48): 6.

[55]揭志軍. 從病例看支氣管擴張癥的不合理處方[J]. 中國社區(qū)醫(yī)師, 2010, 26 (48): 10.

[56]揭志軍. 支氣管擴張癥用藥處方分析——不合理用藥處方分析[J]. 中國臨床醫(yī)生, 2010, 38 (07): 60-64.

[57]揭志軍. 支氣管擴張癥用藥處方分析——合理用藥處方分析[J]. 中國臨床醫(yī)生, 2010, 38 (05): 62-66.

[58]蔡偉文, 揭志軍. 應用激素治療的哮喘病人醫(yī)院真菌感染的危險因素與護理[J]. 護理研究, 2010, 24 (08): 690-692.

[59]揭志軍, 金美玲, 蔡映云, 袁正宏, 胡蕓文, 徐揚. ADAM33基因在慢性哮喘小鼠氣道重塑中的表達[J]. 實用醫(yī)學雜志, 2009, 25 (06): 868-870.

[60]揭志軍, 郭雪君, 徐衛(wèi)國, 王山澤, Kevin Harrod. 呼吸道合胞病毒對小鼠骨髓樹突狀細胞Ⅰ型干擾素信號通路的抑制作用[J]. 上海交通大學學報(醫(yī)學版), 2008, (10): 1262-1265.

[61]金美玲, 揭志軍, 蔡映云, 袁正宏, 胡蕓文, 任濤. CpG寡脫氧核苷酸對慢性哮喘小鼠模型氣道炎癥的預防作用[J]. 復旦學報(醫(yī)學版), 2007, (03): 358-363.

[62]柏宏堅, 孫建, 何禮賢, 揭志軍. 白三烯D4和白介素13對人肺成纖維細胞白三烯受體1 mRNA表達及嗜酸粒細胞趨化因子產生的影響[J]. 現代免疫學, 2007, (01): 32-37.

[63]揭志軍. The effects of CpG-oligodeoxynucleotides on airway remodeling in chronic asthmatic mice[J]. China Medical Abstracts(Internal Medicine), 2006, (04): 212.

[64]揭志軍, 金美玲, 蔡映云, 袁正宏, 胡蕓文, 徐揚, 任濤, 楊振華. 胞嘧啶-磷酸-鳥嘌呤寡脫氧核苷酸對慢性支氣管哮喘小鼠氣道重塑的影響[J]. 中華結核和呼吸雜志, 2006, (09): 612-616.

[65]揭志軍, 金美玲, 蔡映云, 袁正宏, 胡蕓文, 徐楊. 白介素-4和白介素-13促進人肺成纖維細胞ADAM33基因的表達[J]. 復旦學報(醫(yī)學版), 2006, (03): 295-300.

[66]楊振華, 蔡映云, 于堅, 揭志軍, 朱景德. 腫瘤相關基因啟動子甲基化在非小細胞肺癌細胞株中的作用研究[J]. 中國實用內科雜志, 2006, (10): 746-748.

[67]楊振華, 蔡映云, 于堅, 孫麗華, 喬巖, 揭志軍, 朱景德. 啟動子甲基化對抑癌基因轉錄的影響及其5-Aza-CdR干預作用的研究[J]. 臨床內科雜志, 2006, (03): 207-209.

[68]揭志軍, 金美玲, 蔡映云, 袁正宏, 胡蕓文, 徐揚. 白細胞介素-4,-13促進人肺成纖維細胞ADAM33基因的表達[J]. 中華醫(yī)學雜志, 2005, (44): 3148-3149.

[69]揭志軍,蔡映云. 一種新的哮喘易感基因——ADAM33基因[J]. 國外醫(yī)學.呼吸系統(tǒng)分冊, 2005, (09): 647-649.

[70]揭志軍, 羅勇, 徐衛(wèi)國, 林建海, 蔡映云, 宋志芳. 肺損傷程度及其預后與血清中性粒細胞彈性蛋白酶活性的關系[J]. 中國臨床康復, 2005, (35): 96-98.

[71]羅維貴,許杰,揭志軍,李健,王佳,李黎. 抗生素支氣管肺泡灌洗對重癥老年細菌性肺炎患者肺功能及炎癥介質的影響[J]. 醫(yī)學文選, 2005, (04): 463-465.

[72]楊振華 ,蔡映云 ,于堅 ,揭志軍 ,朱景德. 肺癌細胞株抑癌基因啟動子CpG島甲基化與轉錄的關系[J]. 中華內科雜志, 2005, (07): 539-541.

[73]揭志軍,羅勇,徐衛(wèi)國,林建海,宋志芳,蔡映云. 急性肺損傷患者血清中中性粒細胞彈性蛋白酶活性的變化[J]. 中華急診醫(yī)學雜志, 2005, (06): 497-499.

[74]揭志軍,蔡映云. 上皮-間充質營養(yǎng)單位和慢性哮喘[J]. 國外醫(yī)學.呼吸系統(tǒng)分冊, 2004, (06): 410-412.

[75]羅維貴,揭志軍,許杰,李健,盧冬. 激素治療哮喘患者醫(yī)院真菌感染特征與對策的研究[J]. 中華醫(yī)院感染學雜志, 2004, (05): 26-28.

[76]祝慈芳,朱威,揭志軍,蔡映云. α1-抗胰蛋白酶的制備及其防治急性肺損傷的療效[J]. 中國生物制品學雜志, 2004, (01): 39-41.

[77]揭志軍,蔡映云,楊文蘭,金美玲,朱威,祝慈芳. Protective effects of α1 -antitrypsin on acute lung injury in rabbits induced by endotoxin[J]. Chinese Medical Journal, 2003, (11): 80-84.

[78]揭志軍,蔡映云. 淺議我國《慢性阻塞性肺疾病診治指南》[J]. 中華結核和呼吸雜志, 2003, (11): 82-83.

[79]揭志軍,蔡映云,楊文蘭,金美玲,朱威,祝慈芳. α1-ANTITRYPSIN ATTENUATES ENDOTOXIN-INDUCED ACUTE LUNG INJURY IN RABBITS[J]. Journal of Shanghai Second Medical University, 2003, (02): 71-76.

[80]羅維貴,許杰,李健,揭志軍,譚斯藝,鄧凌波. 5種喹諾酮類抗菌劑治療老年性肺炎的療效評價[J]. 中國抗生素雜志, 2003, (06): 364-366+382.

[81]楊文蘭 ,高蓓蘭 ,蔡映云 ,揭志軍. 慢性阻塞性肺部疾病急性發(fā)作期彈性蛋白酶和α1-抗胰蛋白酶的變化[J]. 上海醫(yī)學, 2002, (09): 587-588.

[82]韓鋒鋒,夏韶民,羅勇,徐衛(wèi)國,揭志軍,陸長虹,蔡威. 慢性阻塞性肺病靜息能量消耗與體重指數的關系[J]. 臨床內科雜志, 2002, (05): 340-341.

[83]揭志軍,蔡映云,楊文蘭,金美玲,朱威,祝慈芳. α1-抗胰蛋白酶對急性肺損傷兔蛋白酶和表面活性物質的影響[J]. 中國危重病急救醫(yī)學, 2001, (12): 735-738.

[84]郭忠良,蔡映云,梁永杰,揭志軍,朱蕾. 脈沖振蕩法測定慢性阻塞性肺疾病患者呼吸阻抗與常規(guī)肺功能的關系[J]. 現代康復, 2001, (03): 56-57.

[85]揭志軍,蔡映云,楊文蘭,金美玲,朱威,祝慈芳. 靜脈注射和霧化吸入α1-抗胰蛋白酶對急性肺損傷兔保護作用的比較[J]. 中華內科雜志, 2000, (05): 42-43+75+44.

[86]揭志軍,楊文蘭,蔡映云,金美玲,朱威,祝慈芳. α1抗胰蛋白酶對內毒素致兔急性肺損傷的防護作用[J]. 中華結核和呼吸雜志, 2000, (04): 250-251.

[87]郭忠良,蔡映云,梁永杰,楊文蘭,揭志軍. 穩(wěn)定期中重度慢性阻塞性肺疾病患者運動時胸腹矛盾呼吸以及氧療的作用[J]. 中華結核和呼吸雜志, 2000, (03): 12-14.

[88]郭忠良,蔡映云,梁永杰,楊文蘭,朱蕾,揭志軍. 穩(wěn)定期慢性阻塞性肺疾病患者運動時低氧血癥的發(fā)生及相關因素[J]. 中國康復醫(yī)學雜志, 2000, (01): 14-17.

[89]揭志軍,楊文蘭,蔡映云,金美玲,朱威,祝慈芳. 蛋白酶-抗蛋白酶失衡在內毒素誘發(fā)急性肺損傷中的作用[J]. 中國危重病急救醫(yī)學, 2000, (01): 10-14.

[90]楊文蘭,李惠萍,蔡映云,揭志軍,鄧星奇. 家庭氧療患者氧療知識調查[J]. 上海預防醫(yī)學雜志, 1999, (12): 541-543.

[91]郭忠良,蔡映云,梁永杰,揭志軍,楊文蘭,王美琴. 脈沖振蕩法測定COPD患者靜息時呼吸阻抗與運動能力的關系[J]. 上海醫(yī)學, 1999, (11): 663-666.

[92]揭志軍,楊文蘭. α1-抗胰蛋白酶臨床應用的前景[J]. 國外醫(yī)學.呼吸系統(tǒng)分冊, 1999, (04): 192-194.

[93]揭志軍,楊文蘭,蔡映云. 中性粒細胞彈性蛋白酶在急性肺損傷發(fā)病中的作用[J]. 國外醫(yī)學(內科學分冊), 1999, (10): 439-441.

[94]揭志軍,蔡映云,楊文蘭,金美玲. 外加阻力管對脈沖振蕩法測定呼吸阻抗的影響[J]. 中華結核和呼吸雜志, 1998, (11): 61.

[95]揭志軍. 抗癌藥順鉑緩釋制劑的研究進展[J]. 國外醫(yī)學(腫瘤學分冊), 1997, (06): 338-341.

[96]揭志軍. 內源性呼氣末正壓的發(fā)生機制及其處理[J]. 國外醫(yī)學.呼吸系統(tǒng)分冊, 1997, (04): 214-217.

會議論文：

[1]于云霞 & 揭志軍. (2021). 老年人如何防治流感. (eds.) 健康中國—星巴克助力基層防控新冠肺炎計劃基層呼吸疾病規(guī)范化防診治與健康科普傳播能力提升活動論文集 (pp.250-259).

[2]于云霞 & 揭志軍. (2021). 流感的治療和預防. (eds.) 健康中國—星巴克助力基層防控新冠肺炎計劃基層呼吸疾病規(guī)范化防診治與健康科普傳播能力提升活動論文集 (pp.260-267).

[3]施勁東, 揭志軍, 謝娟, 邵川, 隆玄 &  李善群. (2013). 基質溶解素和金屬蛋白酶組織抑制物在良惡性胸腔積液鑒別診斷中的應用. (eds.) 中華醫(yī)學會呼吸病學年會——2013第十四次全國呼吸病學學術會議論文匯編 (pp.350-351).

[4]施勁東, 何靜, 胡蕓文, 何燕超, 黃琦慧, 梅周芳 &  揭志軍. (2013). 上海地區(qū)2009-2011年老年AECOPD患者病毒感染特點和臨床分析. (eds.) 中華醫(yī)學會呼吸病學年會——2013第十四次全國呼吸病學學術會議論文匯編 (pp.164).

[5]梅周芳, 錢凌, 李小靜 &  揭志軍. (2013). 壞死性肉芽腫性血管炎誤診一例并文獻復習. (eds.) 中華醫(yī)學會呼吸病學年會——2013第十四次全國呼吸病學學術會議論文匯編 (pp.724).

[6]都勇, 施勁東 &  揭志軍. (2013). 非小細胞肺癌與XPD、XRCC1基因多態(tài)性研究. (eds.) 中華醫(yī)學會呼吸病學年會——2013第十四次全國呼吸病學學術會議論文匯編 (pp.351-352).

[7]揭志軍, 馮凈凈, 宋志剛, 張悅 &  郭雪君. (2011). 呼吸道合胞病毒對干擾素信號通路STAT蛋白核轉移的影響. (eds.) 中華醫(yī)學會呼吸病學年會——2011（第十二次全國呼吸病學學術會議）論文匯編 (pp.351-352).

[8]鄧桂勝, 羅勇, 徐衛(wèi)國, 揭志軍 &  王瑩. (2011). 慢性阻塞性肺病患者急性加重期氧化應激與肺功能、最大呼吸肌力動態(tài)變化相關性研究. (eds.) 中華醫(yī)學會呼吸病學年會——2011（第十二次全國呼吸病學學術會議）論文匯編 (pp.413).

[9]揭志軍, 羅勇, 徐衛(wèi)國, 林建海, 蔡映云 &  宋志芳. (2006). 急性肺損傷患者血清中性粒細胞彈性蛋白酶活性的測定幾期臨床意義. (eds.) 2006年全國危重病急救醫(yī)學學術會議論文集 (pp.186).

[10]祝慈芳, 朱威, 揭志軍 &  蔡映云. (2004). α₁-抗胰蛋白酶的制備及其防治急性肺損傷的療效. (eds.) 首屆長三角科技論壇——長三角生物醫(yī)藥發(fā)展論壇論文集 (pp.424-428).

榮譽獎勵：

第三屆上海市“區(qū)域名醫(yī)”，上海市衛(wèi)生系統(tǒng)優(yōu)秀學科帶頭人、閔行領軍人才、上海市優(yōu)秀呼吸醫(yī)師、復旦大學“一健康基金”優(yōu)秀教師獎、復旦大學“優(yōu)秀醫(yī)生”、江川工匠。

1. 2011年，入選閔行區(qū)領軍人才。

2. 上海市第二批衛(wèi)生系統(tǒng)優(yōu)秀學科帶頭人。

3.榮獲2021年度上海市“優(yōu)秀呼吸醫(yī)師”稱號。

4.2016年獲得“上海市優(yōu)秀青年呼吸醫(yī)師”稱號；

5.獲得2015年中華醫(yī)學科技獎一等獎，參與。

6.獲得2017年國家科技進步獎特等獎，以防控人感染H7N9禽流感為代表的新發(fā)傳染病防治體系重大創(chuàng)新和技術突破，李蘭娟; 舒躍龍; 管軼; 馮子健; 袁國勇; 高福; 袁正宏; 王宇; 余宏杰; 王大燕; 高海女; 王辰; 鄭樹森; 楊仕貴; 楊維中; 曹彬; 陳鴻霖; 李群; 朱華晨; 周劍芳; 劉翟; 高榮保; 吳南屏; 胡蕓文; 姚航平; 張曦; 俞亮; 鄭書發(fā); 吳凡; 盧洪洲; 王嘉; 夏時暢; 崔大偉; 白天; 梁偉峰; 林贊育; 武桂珍; 揭志軍; 郭靜; 杜啟泓; 盛吉芳; 刁宏燕; 向妮娟; 楊益大; 趙翔; 湯靈玲; 鄒淑梅; 余斐; 朱丹華。

7.上海市“區(qū)域名醫(yī)”。

8.獲得2021年度上海醫(yī)學科技獎三等獎（第一完成人）。

 

“2013年上海市醫(yī)學會呼吸病學分會區(qū)縣學組年會”在我院召開

由我院主辦，上海市醫(yī)學會呼吸病學分會協(xié)辦的“2013年上海市醫(yī)學會呼吸病學分會區(qū)縣學組年會”于11月28日在我院召開。全市三級、二級醫(yī)院的20多位專家和我院４０余名醫(yī)生參加了此次會議。我院洪洋副院長出席并致歡迎辭，上海醫(yī)學會呼吸病分會主任委員周新教授對區(qū)縣學組的工作做了表揚和指導。

會上，我院呼吸內科揭志軍主任和普陀區(qū)中心醫(yī)院王雄彪主任分別作了“社區(qū)獲得性肺炎初始治療無反應的診斷及應對”和“AECOPD患者管理新視角”的精彩報告；東方醫(yī)院梁永杰主任和楊浦區(qū)中心醫(yī)院羅艷蓉主任也帶來了關于肺部感染的病例討論。現場學術氣氛濃厚而熱烈，與會人員聆聽了最新的學科進展，并進行了熱烈地討論和深入地交流，進一步拓展了臨床診療思路，對促進醫(yī)院呼吸科建設和發(fā)展起到積極推動作用。

來源：復旦大學上海市第五人民醫(yī)院 2013-12-03